a once-daily dry powder inhaler for treatment of COPD in routine clinical practice in a new-user, 1:1 propensity score-matched cohort study. The study included 20,388 propensity score-matched ...

BOSTON — Compared with 17,800 patients starting new inhaled COPD maintenance therapy in 2016 ... the number of patients prescribed to these types of treatments has changed from 2016 to 2022.

Eligible patients had COPD, were ages 40 or older, and were new initiators of these inhalers from 2021 to 2023. They were allowed to be on monotherapy or dual therapy during the year before cohort ...

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

Bronchodilators Don't Improve Smoking-Related Respiratory Symptoms in People Without COPD Sep. 5, 2022 — Researchers have found that dual bronchodilators -- long-lasting inhalers that relax the ...

The US Food and Drug Administration (FDA) has accepted a submission from GSK to review a new indication of ... The study involved 804 COPD patients exhibiting type 2 inflammation, as indicated ...

Researchers say they have found the first new ... COPD flare-ups. If such an attack - involving difficulty breathing, wheezing, coughing and chest tightness - cannot be controlled with regular ...

Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.

Jan. 13, 2025 (GLOBE NEWSWIRE) -- Transpire Bio Inc., an integrated clinical-stage biopharmaceutical company dedicated to developing inhaled medicines, today announced the commencement of a new ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

Budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol ...

WESTON, Fla., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Transpire Bio Inc., an integrated clinical-stage biopharmaceutical company dedicated to developing inhaled medicines, today announced the commencement ...